Data
Downloads
Only datasets CancerIndex may legally redistribute are offered here. Derived ranking snapshots are CancerIndex's own work (CC BY 4.0) and carry attribution rows for the underlying providers. Source datasets under restrictive terms are linked, not mirrored.
CancerIndex-derived
Ranking snapshots (CSV)
One file per metric and scope; header rows carry attribution, formula version, scope, generation time and inputs hash.
| Metric | Scope | Formula | Rows | Generated | Download |
|---|---|---|---|---|---|
| Age-standardized incidence rate | USA · both sexes · all ages · 2023 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2023 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2023 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2022 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2022 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2022 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2021 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2021 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2021 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2020 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2020 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2020 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2019 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2019 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2019 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2018 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2018 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2018 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2017 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2017 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2017 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2016 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2016 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2016 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2015 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2015 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2015 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2014 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2014 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2014 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2013 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2013 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2013 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2012 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2012 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2012 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2011 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2011 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2011 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2010 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2010 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2010 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2009 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2009 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2009 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2008 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2008 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2008 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2007 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2007 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2007 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2006 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2006 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2006 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2005 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2005 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2005 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2004 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2004 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2004 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2003 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2003 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2003 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2002 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2002 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2002 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2001 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2001 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2001 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 2000 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 2000 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 2000 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · both sexes · all ages · 1999 · top-level cancers | ci-asir-v1 | 24 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Female · all ages · 1999 · top-level cancers | ci-asir-v1 | 29 | Sep 29, 2026 | CSV |
| Age-standardized incidence rate | USA · Male · all ages · 1999 · top-level cancers | ci-asir-v1 | 27 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2024 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2024 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2024 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2023 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2023 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2023 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2022 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2022 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2022 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2021 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2021 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2021 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2020 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2020 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2020 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2019 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2019 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2019 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2018 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2018 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2018 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2017 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2017 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2017 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2016 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2016 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2016 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2015 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2015 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2015 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2014 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2014 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2014 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2013 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2013 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2013 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2012 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2012 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2012 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2011 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2011 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2011 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2010 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2010 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2010 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2009 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2009 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2009 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2008 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2008 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2008 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2007 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2007 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2007 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2006 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2006 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2006 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2005 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2005 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2005 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2004 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2004 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2004 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2003 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2003 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2003 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2002 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2002 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2002 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2001 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2001 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2001 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 2000 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 2000 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 2000 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · both sexes · all ages · 1999 · top-level cancers | ci-asmr-v1 | 23 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Female · all ages · 1999 · top-level cancers | ci-asmr-v1 | 28 | Sep 29, 2026 | CSV |
| Age-standardized mortality rate | USA · Male · all ages · 1999 · top-level cancers | ci-asmr-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2024 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2024 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2024 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2023 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2023 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2023 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2022 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2022 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2022 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2021 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2021 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2021 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2020 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2020 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2020 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2019 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2019 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2019 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2018 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2018 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2018 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2017 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2017 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2017 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2016 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2016 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2016 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2015 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2015 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2015 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2014 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2014 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2014 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2013 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2013 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2013 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2012 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2012 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2012 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2011 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2011 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2011 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2010 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2010 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2010 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2009 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2009 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2009 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2008 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2008 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2008 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2007 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2007 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2007 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2006 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2006 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2006 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2005 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2005 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2005 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2004 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2004 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2004 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2003 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2003 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2003 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2002 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2002 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2002 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2001 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2001 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2001 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 2000 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 2000 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 2000 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual deaths | USA · both sexes · all ages · 1999 · top-level cancers | ci-mortality-count-v1 | 31 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Female · all ages · 1999 · top-level cancers | ci-mortality-count-v1 | 28 | Sep 29, 2026 | CSV |
| Annual deaths | USA · Male · all ages · 1999 · top-level cancers | ci-mortality-count-v1 | 26 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2023 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2023 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2023 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2022 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2022 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2022 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2021 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2021 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2021 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2020 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2020 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2020 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2019 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2019 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2019 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2018 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2018 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2018 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2017 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2017 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2017 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2016 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2016 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2016 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2015 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2015 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2015 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2014 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2014 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2014 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2013 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2013 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2013 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2012 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2012 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2012 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2011 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2011 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2011 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2010 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2010 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2010 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2009 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2009 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2009 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2008 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2008 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2008 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2007 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2007 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2007 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2006 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2006 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2006 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2005 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2005 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2005 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2004 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2004 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2004 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2003 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2003 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2003 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2002 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2002 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2002 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2001 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2001 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2001 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 2000 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 2000 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 2000 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Annual new cases | USA · both sexes · all ages · 1999 · top-level cancers | ci-incidence-count-v1 | 32 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Female · all ages · 1999 · top-level cancers | ci-incidence-count-v1 | 29 | Sep 29, 2026 | CSV |
| Annual new cases | USA · Male · all ages · 1999 · top-level cancers | ci-incidence-count-v1 | 27 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2023 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2023 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2023 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2022 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2022 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2022 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2021 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2021 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2021 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2020 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2020 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2020 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2019 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2019 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2019 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2018 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2018 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2018 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2017 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2017 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2017 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2016 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2016 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2016 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2015 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2015 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2015 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2014 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2014 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2014 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2013 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2013 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2013 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2012 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2012 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2012 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2011 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2011 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2011 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2010 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2010 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2010 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2009 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2009 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2009 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2008 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2008 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2008 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2007 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2007 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2007 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2006 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2006 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2006 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2005 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2005 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2005 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2004 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2004 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2004 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2003 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2003 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2003 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2002 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2002 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2002 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2001 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2001 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2001 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 2000 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 2000 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 2000 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · both sexes · all ages · 1999 · top-level cancers | ci-mir-v1 | 31 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Female · all ages · 1999 · top-level cancers | ci-mir-v1 | 28 | Sep 29, 2026 | CSV |
| Mortality-to-incidence ratio | USA · Male · all ages · 1999 · top-level cancers | ci-mir-v1 | 26 | Sep 29, 2026 | CSV |
| Curated clinical evidence items | World · both sexes · all ages · latest · top-level cancers | ci-civic-evidence-v1 | 28 | Sep 29, 2026 | CSV |
| Curated clinical evidence items | World · both sexes · all ages · latest · all malignant entities | ci-civic-evidence-v1 | 492 | Sep 29, 2026 | CSV |
| Genes with curated or cohort evidence | World · both sexes · all ages · latest · top-level cancers | ci-genes-v1 | 30 | Sep 29, 2026 | CSV |
| Genes with curated or cohort evidence | World · both sexes · all ages · latest · all malignant entities | ci-genes-v1 | 521 | Sep 29, 2026 | CSV |
| Public genomic cohorts | World · both sexes · all ages · latest · top-level cancers | ci-cohorts-v1 | 27 | Sep 29, 2026 | CSV |
| Public genomic cohorts | World · both sexes · all ages · latest · all malignant entities | ci-cohorts-v1 | 296 | Sep 29, 2026 | CSV |
| Publications, last 12 months | World · both sexes · all ages · latest · top-level cancers | ci-pubs-12m-v1 | 36 | Sep 29, 2026 | CSV |
| Publications, last 12 months | World · both sexes · all ages · latest · all malignant entities | ci-pubs-12m-v1 | 2,294 | Sep 29, 2026 | CSV |
| Publications, last 5 years | World · both sexes · all ages · latest · top-level cancers | ci-pubs-5y-v1 | 36 | Sep 29, 2026 | CSV |
| Publications, last 5 years | World · both sexes · all ages · latest · all malignant entities | ci-pubs-5y-v1 | 2,873 | Sep 29, 2026 | CSV |
| Publication growth | World · both sexes · all ages · latest · top-level cancers | ci-pub-growth-v1 | 36 | Sep 29, 2026 | CSV |
| Publication growth | World · both sexes · all ages · latest · all malignant entities | ci-pub-growth-v1 | 286 | Sep 29, 2026 | CSV |
| Trial registration growth (year over year) | World · both sexes · all ages · latest · top-level cancers | ci-trial-growth-v1 | 24 | Sep 29, 2026 | CSV |
| Trial registration growth (year over year) | World · both sexes · all ages · latest · all malignant entities | ci-trial-growth-v1 | 186 | Sep 29, 2026 | CSV |
| Active clinical trials | World · both sexes · all ages · latest · top-level cancers | ci-active-trials-v1 | 36 | Sep 29, 2026 | CSV |
| Active clinical trials | World · both sexes · all ages · latest · all malignant entities | ci-active-trials-v1 | 1,654 | Sep 29, 2026 | CSV |
| Active Phase III trials | World · both sexes · all ages · latest · top-level cancers | ci-phase3-trials-v1 | 36 | Sep 29, 2026 | CSV |
| Active Phase III trials | World · both sexes · all ages · latest · all malignant entities | ci-phase3-trials-v1 | 810 | Sep 29, 2026 | CSV |
| Recruiting clinical trials | World · both sexes · all ages · latest · top-level cancers | ci-recruiting-trials-v1 | 36 | Sep 29, 2026 | CSV |
| Recruiting clinical trials | World · both sexes · all ages · latest · all malignant entities | ci-recruiting-trials-v1 | 1,277 | Sep 29, 2026 | CSV |
| Recruiting Phase III trials | World · both sexes · all ages · latest · top-level cancers | ci-phase3-recruiting-v1 | 33 | Sep 29, 2026 | CSV |
| Recruiting Phase III trials | World · both sexes · all ages · latest · all malignant entities | ci-phase3-recruiting-v1 | 585 | Sep 29, 2026 | CSV |
| Sponsor concentration (HHI) | World · both sexes · all ages · latest · top-level cancers | ci-sponsor-hhi-v1 | 36 | Sep 29, 2026 | CSV |
| Sponsor concentration (HHI) | World · both sexes · all ages · latest · all malignant entities | ci-sponsor-hhi-v1 | 615 | Sep 29, 2026 | CSV |
| Trial termination share | World · both sexes · all ages · latest · top-level cancers | ci-trial-termination-v1 | 34 | Sep 29, 2026 | CSV |
| Trial termination share | World · both sexes · all ages · latest · all malignant entities | ci-trial-termination-v1 | 454 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2024 · top-level cancers | ci-trials-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2024 · top-level cancers | ci-trials-per-deaths-v1 | 32 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2024 · top-level cancers | ci-trials-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2023 · top-level cancers | ci-trials-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2023 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2023 · top-level cancers | ci-trials-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2022 · top-level cancers | ci-trials-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2022 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2022 · top-level cancers | ci-trials-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2021 · top-level cancers | ci-trials-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2021 · top-level cancers | ci-trials-per-deaths-v1 | 32 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2021 · top-level cancers | ci-trials-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2020 · top-level cancers | ci-trials-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2020 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2020 · top-level cancers | ci-trials-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2019 · top-level cancers | ci-trials-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2019 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2019 · top-level cancers | ci-trials-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2018 · top-level cancers | ci-trials-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2018 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2018 · top-level cancers | ci-trials-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2017 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2017 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2017 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2016 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2016 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2016 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2015 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2015 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2015 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2014 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2014 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2014 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2013 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2013 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2013 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2012 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2012 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2012 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2011 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2011 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2011 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2010 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2010 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2010 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2009 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2009 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2009 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2008 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2008 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2008 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2007 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2007 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2007 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2006 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2006 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2006 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2005 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2005 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2005 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2004 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2004 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2004 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2003 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2003 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2003 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2002 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2002 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2002 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2001 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2001 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2001 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 2000 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 2000 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 2000 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · both sexes · all ages · 1999 · top-level cancers | ci-trials-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Female · all ages · 1999 · top-level cancers | ci-trials-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Active trials per 1,000 annual deaths | USA · Male · all ages · 1999 · top-level cancers | ci-trials-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2024 · top-level cancers | ci-pubs-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2024 · top-level cancers | ci-pubs-per-deaths-v1 | 32 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2024 · top-level cancers | ci-pubs-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2023 · top-level cancers | ci-pubs-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2023 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2023 · top-level cancers | ci-pubs-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2022 · top-level cancers | ci-pubs-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2022 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2022 · top-level cancers | ci-pubs-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2021 · top-level cancers | ci-pubs-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2021 · top-level cancers | ci-pubs-per-deaths-v1 | 32 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2021 · top-level cancers | ci-pubs-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2020 · top-level cancers | ci-pubs-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2020 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2020 · top-level cancers | ci-pubs-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2019 · top-level cancers | ci-pubs-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2019 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2019 · top-level cancers | ci-pubs-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2018 · top-level cancers | ci-pubs-per-deaths-v1 | 35 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2018 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2018 · top-level cancers | ci-pubs-per-deaths-v1 | 30 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2017 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2017 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2017 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2016 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2016 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2016 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2015 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2015 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2015 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2014 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2014 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2014 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2013 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2013 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2013 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2012 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2012 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2012 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2011 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2011 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2011 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2010 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2010 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2010 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2009 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2009 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2009 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2008 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2008 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2008 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2007 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2007 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2007 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2006 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2006 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2006 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2005 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2005 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2005 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2004 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2004 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2004 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2003 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2003 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2003 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2002 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2002 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2002 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2001 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2001 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2001 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 2000 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 2000 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 2000 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · both sexes · all ages · 1999 · top-level cancers | ci-pubs-per-deaths-v1 | 31 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Female · all ages · 1999 · top-level cancers | ci-pubs-per-deaths-v1 | 27 | Sep 29, 2026 | CSV |
| Publications (5 y) per 1,000 annual deaths | USA · Male · all ages · 1999 · top-level cancers | ci-pubs-per-deaths-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2024 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2024 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2024 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2023 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2023 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2023 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2022 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2022 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2022 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2021 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2021 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2021 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2020 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2020 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2020 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2019 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2019 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2019 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2018 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2018 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2018 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2017 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2017 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2017 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2016 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2016 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2016 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2015 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2015 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2015 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2014 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2014 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2014 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2013 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2013 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2013 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2012 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2012 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2012 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2011 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2011 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2011 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2010 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2010 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2010 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2009 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2009 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2009 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2008 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2008 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2008 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2007 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2007 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2007 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2006 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2006 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2006 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2005 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2005 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2005 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2004 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2004 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2004 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2003 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2003 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2003 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2002 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2002 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2002 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2001 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2001 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2001 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 2000 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 2000 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 2000 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · both sexes · all ages · 1999 · top-level cancers | ci-research-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Female · all ages · 1999 · top-level cancers | ci-research-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Research Gap Index | USA · Male · all ages · 1999 · top-level cancers | ci-research-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2024 · top-level cancers | ci-research-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2024 · top-level cancers | ci-research-gap-ratio-v1 | 32 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2024 · top-level cancers | ci-research-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2023 · top-level cancers | ci-research-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2023 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2023 · top-level cancers | ci-research-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2022 · top-level cancers | ci-research-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2022 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2022 · top-level cancers | ci-research-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2021 · top-level cancers | ci-research-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2021 · top-level cancers | ci-research-gap-ratio-v1 | 32 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2021 · top-level cancers | ci-research-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2020 · top-level cancers | ci-research-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2020 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2020 · top-level cancers | ci-research-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2019 · top-level cancers | ci-research-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2019 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2019 · top-level cancers | ci-research-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2018 · top-level cancers | ci-research-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2018 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2018 · top-level cancers | ci-research-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2017 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2017 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2017 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2016 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2016 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2016 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2015 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2015 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2015 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2014 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2014 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2014 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2013 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2013 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2013 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2012 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2012 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2012 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2011 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2011 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2011 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2010 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2010 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2010 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2009 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2009 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2009 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2008 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2008 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2008 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2007 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2007 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2007 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2006 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2006 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2006 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2005 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2005 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2005 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2004 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2004 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2004 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2003 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2003 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2003 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2002 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2002 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2002 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2001 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2001 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2001 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 2000 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 2000 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 2000 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · both sexes · all ages · 1999 · top-level cancers | ci-research-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Female · all ages · 1999 · top-level cancers | ci-research-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Research Gap Ratio | USA · Male · all ages · 1999 · top-level cancers | ci-research-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2024 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2024 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2024 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2023 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2023 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2023 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2022 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2022 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2022 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2021 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2021 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2021 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2020 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2020 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2020 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2019 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2019 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2019 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2018 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2018 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2018 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2017 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2017 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2017 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2016 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2016 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2016 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2015 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2015 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2015 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2014 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2014 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2014 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2013 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2013 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2013 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2012 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2012 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2012 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2011 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2011 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2011 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2010 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2010 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2010 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2009 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2009 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2009 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2008 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2008 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2008 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2007 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2007 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2007 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2006 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2006 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2006 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2005 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2005 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2005 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2004 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2004 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2004 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2003 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2003 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2003 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2002 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2002 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2002 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2001 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2001 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2001 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 2000 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 2000 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 2000 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · both sexes · all ages · 1999 · top-level cancers | ci-trial-gap-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Female · all ages · 1999 · top-level cancers | ci-trial-gap-v1 | 28 | Sep 29, 2026 | CSV |
| Trial Gap Index | USA · Male · all ages · 1999 · top-level cancers | ci-trial-gap-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2024 · top-level cancers | ci-trial-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2024 · top-level cancers | ci-trial-gap-ratio-v1 | 32 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2024 · top-level cancers | ci-trial-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2023 · top-level cancers | ci-trial-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2023 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2023 · top-level cancers | ci-trial-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2022 · top-level cancers | ci-trial-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2022 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2022 · top-level cancers | ci-trial-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2021 · top-level cancers | ci-trial-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2021 · top-level cancers | ci-trial-gap-ratio-v1 | 32 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2021 · top-level cancers | ci-trial-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2020 · top-level cancers | ci-trial-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2020 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2020 · top-level cancers | ci-trial-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2019 · top-level cancers | ci-trial-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2019 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2019 · top-level cancers | ci-trial-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2018 · top-level cancers | ci-trial-gap-ratio-v1 | 35 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2018 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2018 · top-level cancers | ci-trial-gap-ratio-v1 | 30 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2017 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2017 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2017 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2016 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2016 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2016 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2015 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2015 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2015 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2014 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2014 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2014 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2013 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2013 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2013 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2012 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2012 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2012 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2011 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2011 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2011 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2010 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2010 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2010 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2009 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2009 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2009 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2008 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2008 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2008 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2007 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2007 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2007 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2006 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2006 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2006 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2005 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2005 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2005 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2004 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2004 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2004 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2003 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2003 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2003 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2002 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2002 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2002 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2001 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2001 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2001 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 2000 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 2000 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 2000 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · both sexes · all ages · 1999 · top-level cancers | ci-trial-gap-ratio-v1 | 31 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Female · all ages · 1999 · top-level cancers | ci-trial-gap-ratio-v1 | 27 | Sep 29, 2026 | CSV |
| Trial Gap Ratio | USA · Male · all ages · 1999 · top-level cancers | ci-trial-gap-ratio-v1 | 26 | Sep 29, 2026 | CSV |
Upstream
Source datasets
Redistribution terms as reviewed. Restricted sources are linked to their official download pages instead.
Redistributable with attribution
- CDC WONDER — Underlying Cause of Death (US mortality by ICD-10 site)attribution
- SEER API (Surveillance, Epidemiology, and End Results Program)attribution
- SEER*Explorer (SEER statistics exports)attribution
- U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortalityattribution
- CIViC — Clinical Interpretation of Variants in Cancerallowed
- HGNC — HUGO Gene Nomenclature Committeeallowed
- NCI Genomic Data Commons (open aggregated data)attribution
- PubMed (NCBI E-utilities)attribution
- NCI Thesaurus (NCIt)attribution
- OncoTreeattribution
- ClinicalTrials.govattribution
- NCBI ClinVar (variant_summary)attribution
- ChEMBL (EMBL-EBI)attribution
- cBioPortal for Cancer Genomics (public studies)attribution
- MeSH — Medical Subject Headings (NLM)attribution
- EMA — European public assessment reports (centrally authorised medicines)attribution
- Health Canada — Drug Product Database (DPD)attribution
- openFDA — Drugs@FDA applications and drug labels (SPL)allowed
Restricted or under review
Attribution for derived files: "CancerIndex (cancerindex.io), CC BY 4.0; underlying data © respective providers." The public API at /api/v1 returns the same data with a sources array in every envelope.